Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

4-7-8 Breathing Exercises for Stress, Well-Being, and Quality of Life in Newly Diagnosed Type 2 Diabetes

14 november 2026 bijgewerkt door: EMRE ERKAL, Artvin Coruh University

Effects of 4-7-8 Breathing Exercises on Perceived Stress, Mental Well-Being, and Quality of Life in Newly Diagnosed Patients With Type 2 Diabetes

This randomized controlled trial aims to evaluate the effects of 4-7-8 breathing exercises on perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus.

The study will be conducted at the Internal Medicine Outpatient Clinic of Kayseri City Hospital, Türkiye. A total of 60 patients aged 18-65 years who have been newly diagnosed with type 2 diabetes mellitus and have HbA1c levels of 8% or higher will be enrolled. Participants will be randomly assigned to either the intervention group (n=30) or the control group (n=30) using simple randomization.

Participants in the intervention group will perform 4-7-8 breathing exercises twice daily, in the morning and evening, for four weeks, in addition to receiving routine diabetes treatment. The breathing technique involves inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling through the mouth for 8 seconds. Participants will be instructed to perform four sets per session. Participants in the control group will continue receiving routine diabetes treatment without any additional breathing exercises.

Data will be collected at baseline and at the end of the four-week intervention using the Perceived Stress Scale (PSS-14), the World Health Organization-Five Well-Being Index (WHO-5), and the Short Form-36 Health Survey (SF-36).

The study will investigate whether 4-7-8 breathing exercises improve perceived stress, mental well-being, and quality of life in newly diagnosed patients with type 2 diabetes mellitus compared with routine care alone.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that requires continuous treatment, lifestyle modifications, and self-management. Receiving a new diagnosis of T2DM may lead to psychological distress, uncertainty, and difficulties adapting to disease-related responsibilities. These challenges may negatively affect perceived stress, mental well-being, and quality of life during the early stages of disease management.

Controlled breathing exercises are non-pharmacological interventions that may help regulate physiological and psychological responses to stress. The 4-7-8 breathing technique involves a structured breathing pattern designed to promote relaxation through controlled inhalation, breath-holding, and prolonged exhalation. Although previous studies have investigated various breathing techniques in individuals with T2DM, evidence regarding the effects of 4-7-8 breathing exercises specifically in newly diagnosed patients remains limited.

This study is designed as a two-arm, parallel-group randomized controlled trial to investigate the effectiveness of 4-7-8 breathing exercises as a complementary intervention alongside routine diabetes treatment.

Following eligibility assessment and informed consent, participants will complete baseline assessments and be randomly allocated to the intervention or control group. Participants assigned to the intervention group will receive instructions on performing the 4-7-8 breathing technique and will practice the exercises twice daily for four weeks. Participants in both groups will continue their routine diabetes treatment throughout the study.

The study will assess three patient-reported outcomes: perceived stress, mental well-being, and health-related quality of life. Perceived stress will be evaluated using the 14-item Perceived Stress Scale (PSS-14), with higher scores indicating greater perceived stress. Mental well-being will be assessed using the WHO-5 Well-Being Index, with higher scores indicating better well-being. Health-related quality of life will be measured using the SF-36 Health Survey, which evaluates eight dimensions of physical and mental health.

Outcome assessments will be conducted at baseline and after the four-week intervention. The collected data will be analyzed using appropriate statistical methods to examine changes within groups and differences between groups.

The findings are expected to contribute to the evidence regarding the potential role of 4-7-8 breathing exercises as a simple, accessible, and non-pharmacological supportive intervention for patients newly diagnosed with T2DM.

Studietype

Ingrijpend

Inschrijving (Geschat)

60

Fase

  • Niet toepasbaar

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Being between 18 and 65 years of age.
  • Having a new diagnosis of type 2 diabetes mellitus.
  • Having an HbA1c level of ≥8%.
  • Having initiated insulin and/or oral antidiabetic treatment.
  • Having no communication difficulties.
  • Having no respiratory disorders (e.g., asthma or chronic obstructive pulmonary disease).
  • Being willing to participate in the study.

Exclusion Criteria:

  • Presence of respiratory disorders, such as asthma or chronic obstructive pulmonary disease (COPD).
  • Presence of communication difficulties that prevent participation in the study.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: 4-7-8 Breathing Exercise Group

Participants in the experimental group will perform 4-7-8 breathing exercises twice daily (morning and evening), with four sets per session, for four weeks. Each breathing cycle consists of inhaling through the nose for 4 seconds, holding the breath for 7 seconds, and exhaling slowly through the mouth for 8 seconds. Participants will continue receiving their routine diabetes treatment throughout the intervention period.

Participants in the intervention group will perform the 4-7-8 breathing exercise for four weeks in addition to their routine diabetes treatment. The technique consists of three consecutive steps: (1) exhaling completely through the mouth while making a whooshing sound; (2) closing the mouth, inhaling quietly through the nose for 4 seconds, and holding the breath for 7 seconds; and (3) exhaling slowly through the mouth for 8 seconds while making a whooshing sound. Participants will be instructed to perform the exercise twice daily, in the morning and evening, with four sets per session. Routine diabetes treatment will continue throughout the intervention period.

Geen tussenkomst: Routine Care Group

Participants in the control group will continue receiving routine diabetes treatment without performing 4-7-8 breathing exercises or receiving any additional breathing intervention during the four-week study period.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Perceived Stress Scale (PSS-14) Score From Baseline to Week 4
Tijdsspanne: Baseline, Week 4

Perceived stress will be assessed using the 14-item Perceived Stress Scale (PSS-14). Each item is rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often). Total scores range from 0 to 56, with higher scores indicating greater perceived stress. The outcome will be assessed as the change in total PSS-14 score from baseline to Week 4. A decrease in the total score indicates a reduction in perceived stress.

Baseline, Week 4

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in WHO-5 Well-Being Index Score From Baseline to Week 4
Tijdsspanne: Baseline, Week 4

Mental well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5). The instrument consists of five items, each scored from 0 (at no time) to 5 (all of the time). The raw total score ranges from 0 to 25, with higher scores indicating better mental well-being. The outcome will be assessed as the change in the raw total WHO-5 score from baseline to Week 4. An increase in the score indicates improved mental well-being.

Baseline, Week 4
Secondary Outcome 2 - Quality of Life (SF-36)
Tijdsspanne: Baseline, Week 4

Health-related quality of life will be assessed using the 36-Item Short Form Health Survey (SF-36). The instrument consists of 36 items evaluating eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored separately from 0 to 100, with higher scores indicating better health-related quality of life. Changes in the eight domain scores from baseline to Week 4 will be evaluated. The SF-36 does not provide a single overall total score.

Baseline, Week 4

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

16 november 2026

Primaire voltooiing (Geschat)

16 november 2027

Studie voltooiing (Geschat)

16 november 2027

Studieregistratiedata

Eerst ingediend

10 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

14 november 2026

Eerst geplaatst (Werkelijk)

17 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 november 2026

Laatste update ingediend die voldeed aan QC-criteria

14 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • T2DM-478-RCT-2026

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .